191 related articles for article (PubMed ID: 37980372)
1. Construction of an anoikis-associated lncRNA-miRNA-mRNA network reveals the prognostic role of β-elemene in non-small cell lung cancer.
Tan K; Zhang C; He Z; Zeng P
Sci Rep; 2023 Nov; 13(1):20185. PubMed ID: 37980372
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome Sequencing Analysis of the Effect of
Deng H; Chen S; Yuan X; Zhang J
Genet Res (Camb); 2022; 2022():5896296. PubMed ID: 36160034
[No Abstract] [Full Text] [Related]
3. β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer.
Xu C; Jiang ZB; Shao L; Zhao ZM; Fan XX; Sui X; Yu LL; Wang XR; Zhang RN; Wang WJ; Xie YJ; Zhang YZ; Nie XW; Xie C; Huang JM; Wang J; Wang J; Leung EL; Wu QB
Pharmacol Res; 2023 May; 191():106739. PubMed ID: 36948327
[TBL] [Abstract][Full Text] [Related]
4. The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer.
Guo Q; Li D; Luo X; Yuan Y; Li T; Liu H; Wang X
Front Immunol; 2021; 12():684807. PubMed ID: 34394080
[TBL] [Abstract][Full Text] [Related]
5. β-elemene suppresses Warburg effect in NCI-H1650 non-small-cell lung cancer cells by regulating the miR-301a-3p/AMPKα axis.
Li L; Zhao D; Cheng G; Li Q; Chu Y; Chu H; Ding Y; Li C
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32463461
[TBL] [Abstract][Full Text] [Related]
6. Identification of A novel anoikis-related genes-based signature for non-small cell lung cancer.
Lei J; Guo G; Liang D; Gong L; Zhang L; Wang X
Biochem Biophys Res Commun; 2023 Sep; 673():137-144. PubMed ID: 37385008
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer.
Zhao H; Huang Y; Tong G; Wu W; Ren Y
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003378
[TBL] [Abstract][Full Text] [Related]
8. Anoikis-related gene signature is associated with immune infiltration and predicts the prognosis of non-small cell lung cancer.
Wu Y; Zhou Z; Qi Q; Xu S; Chen L; Wang F
Aging (Albany NY); 2024 Feb; 16(3):2908-2933. PubMed ID: 38329444
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer.
Yang CZ; Hu LH; Huang ZY; Deng L; Guo W; Liu S; Xiao X; Yang HX; Lin JT; Sun LL; Lin LZ
PLoS One; 2021; 16(12):e0260720. PubMed ID: 34855841
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death.
Wang G; Li X; Huang F; Zhao J; Ding H; Cunningham C; Coad JE; Flynn DC; Reed E; Li QQ
Cell Mol Life Sci; 2005 Apr; 62(7-8):881-93. PubMed ID: 15868411
[TBL] [Abstract][Full Text] [Related]
11. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
12. Costimulatory molecule-related lncRNA model as a potential prognostic biomarker in non-small cell lung cancer.
Yao Y; Yang F; Chen A; Hua Q; Gao W
Cancer Med; 2023 Mar; 12(5):6419-6436. PubMed ID: 36305249
[TBL] [Abstract][Full Text] [Related]
13. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
14. Construction of lncRNA TYMSOS/hsa-miR-101-3p/CEP55 and TYMSOS/hsa-miR-195-5p/CHEK1 Axis in Non-small Cell Lung Cancer.
Ji L; Yang T; Liu M; Li J; Si Q; Wang Y; Liu J; Dai L
Biochem Genet; 2023 Jun; 61(3):995-1014. PubMed ID: 36352081
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
[TBL] [Abstract][Full Text] [Related]
16. β-elemene inhibited expression of DNA methyltransferase 1 through activation of ERK1/2 and AMPKα signalling pathways in human lung cancer cells: the role of Sp1.
Zhao S; Wu J; Zheng F; Tang Q; Yang L; Li L; Wu W; Hann SS
J Cell Mol Med; 2015 Mar; 19(3):630-41. PubMed ID: 25598321
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
Chen ZY; Liu HY; Jiang N; Yuan JM
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of lncRNA gene characteristics based on PD-1 immune related pathway for the prediction of non-small cell lung cancer prognosis.
Chen H; Xu S; Zhang Y; Chen P
Math Biosci Eng; 2023 Mar; 20(6):9818-9838. PubMed ID: 37322912
[TBL] [Abstract][Full Text] [Related]
20. Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs.
Deng H; Wei Z; Du J; Shen Z; Zhou C
Eur J Med Res; 2023 Nov; 28(1):548. PubMed ID: 38017579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
